Sage Therapeutics (SAGE) Stock Chart & Stock Price History $8.68 0.00 (0.00%) As of 07/31/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Sage Therapeutics Stock Price Performance The Sage Therapeutics (SAGE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 4.83%, with a year-to-date return of 59.85%. In the past month, the stock has decreased 5.24%, reflecting recent market activity. As of the latest close, Sage Therapeutics traded at $8.68 with a market cap of $543.54 million and volume of 0 shares. Five years ago, the stock traded at $50.70, representing a 82.88% decrease over that period. At the time, it had a market cap of $2.63 billion and a volume of 645,375 shares. Receive SAGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.07%1 Month Performance-5.24%3 Month Performance+29.07%Year-To-Date Performance+59.85%1 Year Performance+4.83%5 Year Performance-82.88% SAGE Stock Chart for Friday, August, 8, 2025 SAGE Chart by TradingView Sage Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$8.69$8.69$8.74$8.6822.70 million shs$543.92 million07/31/2025$8.68$8.69+0.07%$8.74$8.6822.70 million shs$543.93 million07/30/2025$8.70$8.68-0.23%$8.74$8.6822.69 million shs$543.54 million07/29/2025$8.78$8.70-0.91%$8.77$8.707.38 million shs$544.79 million07/28/2025$8.80$8.78-0.23%$8.81$8.774.34 million shs$549.81 million07/25/2025$8.76$8.80+0.46%$8.82$8.762.93 million shs$551.07 million07/24/2025$8.77$8.76-0.11%$8.79$8.751.99 million shs$548.55 million07/23/2025$8.75$8.77+0.23%$8.80$8.712.65 million shs$549.18 million07/22/2025$8.97$8.75-2.45%$8.85$8.7410.97 million shs$547.93 million07/21/2025$9.11$8.97-1.54%$9.10$8.962.08 million shs$561.70 million Get the Latest News and Ratings for SAGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$9.14$9.11-0.33%$9.17$9.101.94 million shs$570.47 million07/17/2025$9.13$9.14+0.11%$9.17$9.131.14 million shs$572.35 million07/16/2025$9.17$9.13-0.44%$9.19$9.111.62 million shs$571.73 million07/15/2025$9.15$9.17+0.22%$9.19$9.101.07 million shs$574.23 million07/14/2025$9.27$9.15-1.29%$9.23$9.102.23 million shs$572.97 million07/11/2025$9.21$9.27+0.65%$9.36$9.133.06 million shs$580.49 million07/10/2025$9.20$9.21+0.11%$9.25$9.161.55 million shs$576.73 million07/09/2025$9.16$9.20+0.44%$9.24$9.141.39 million shs$576.11 million07/08/2025$9.17$9.16-0.11%$9.20$9.101.83 million shs$573.60 million07/07/2025$9.20$9.17-0.27%$9.20$9.111.46 million shs$574.23 million Related Companies IDEAYA Biosciences Stock Chart Bausch Health Cos Stock Chart Belite Bio Stock Chart ImmunityBio Stock Chart Disc Medicine Stock Chart Agios Pharmaceuticals Stock Chart Twist Bioscience Stock Chart CG Oncology Stock Chart Harmony Biosciences Stock Chart Denali Therapeutics Stock Chart Receive SAGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sage Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SAGE) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sage Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sage Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
